- Home
- BMRA vs SHPH Comparison
BMRA vs SHPH Comparison
Compare BMRA & SHPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMRA
- SHPH
- Stock Information
- Founded
- BMRA 1971
- SHPH 2012
- Country
- BMRA United States
- SHPH United States
- Employees
- BMRA N/A
- SHPH N/A
- Industry
- BMRA Biotechnology: In Vitro & In Vivo Diagnostic Substances
- SHPH Biotechnology: Pharmaceutical Preparations
- Sector
- BMRA Health Care
- SHPH Health Care
- Exchange
- BMRA Nasdaq
- SHPH Nasdaq
- Market Cap
- BMRA 7.4M
- SHPH 3.3M
- IPO Year
- BMRA N/A
- SHPH 2022
- Fundamental
- Price
- BMRA $0.33
- SHPH $1.29
- Analyst Decision
- BMRA
- SHPH
- Analyst Count
- BMRA 0
- SHPH 0
- Target Price
- BMRA N/A
- SHPH N/A
- AVG Volume (30 Days)
- BMRA 68.2K
- SHPH 42.2K
- Earning Date
- BMRA 10-15-2024
- SHPH 11-12-2024
- Dividend Yield
- BMRA N/A
- SHPH N/A
- EPS Growth
- BMRA N/A
- SHPH N/A
- EPS
- BMRA N/A
- SHPH N/A
- Revenue
- BMRA $5,509,000.00
- SHPH N/A
- Revenue This Year
- BMRA N/A
- SHPH N/A
- Revenue Next Year
- BMRA N/A
- SHPH N/A
- P/E Ratio
- BMRA N/A
- SHPH N/A
- Revenue Growth
- BMRA 1.74
- SHPH N/A
- 52 Week Low
- BMRA $0.24
- SHPH $1.03
- 52 Week High
- BMRA $2.13
- SHPH $4.96
- Technical
- Relative Strength Index (RSI)
- BMRA 47.85
- SHPH 46.55
- Support Level
- BMRA $0.28
- SHPH $1.12
- Resistance Level
- BMRA $0.35
- SHPH $1.26
- Average True Range (ATR)
- BMRA 0.04
- SHPH 0.11
- MACD
- BMRA 0.00
- SHPH 0.05
- Stochastic Oscillator
- BMRA 41.67
- SHPH 59.09
About BMRA Biomerica Inc.
Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates in one segment namely, the design, development, marketing and sales of diagnostic kits. The majority of the company's revenue is earned from the Europe market.
About SHPH Shuttle Pharmaceuticals Holdings Inc.
Shuttle Pharmaceuticals Holdings Inc is a clinical stage pharmaceutical company leveraging our proprietary technology to develop novel therapies designed to cure cancers. The company's goal is to extend the benefits of cancer treatments by leveraging insights into the pillars of cancer therapy: surgery, radiation therapy, chemotherapy, and immunotherapy.